Management of primary vesicoureteral reflux in children: editorial commentary.
Decisions are needed about the clinical management of children with vesicoureteral reflux (VUR) and a standardized risk-specific treatment approach is needed. Clinicians and researchers must begin to think creatively about VUR. Clinicians are beginning to understand that there are a variety of abnormalities in specific host defenses that might predispose some children to recurrent urinary tract infection, and that knowledge of these deficiencies may lead to therapies designed to compensate for them. There is also much to be learned about host inflammatory response to kidney infection.